• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Eisai eventually buying Arena?









Of course Eisai is going to by Arena…Arena is in bad shape and makes absolutely zero sense at all for Eisai to buy them…but alas Eisai will not let intelligence and business acumen get in the way of bad decision making. Not to mention they will overpay by about 40%...
 




Of course Eisai is going to by Arena…Arena is in bad shape and makes absolutely zero sense at all for Eisai to buy them…but alas Eisai will not let intelligence and business acumen get in the way of bad decision making. Not to mention they will overpay by about 40%...

How did you get a copy of the minutes from the last Executive Committee meeting?!!??!!!